Opioid Use Disorder

A multilevel program that provided support and resources to rural primary care practices was associated with an increase in buprenorphine prescriptions, data show.

HIV PrEP uptake and adherence were low among a cohort of people with opioid use disorder who were undergoing treatment for hepatitis C virus, despite many of them meeting CDC criteria for PrEP use, according to a study.

A new medical education curriculum in an area hit hard by the opioid epidemic will help fill a gap in addiction management training, according to a press release.

The FDA is warning patients and health care professionals that transmucosal buprenorphine products may cause tooth decay, cavities, oral infections and tooth loss, even in patients with no prior history of dental issues.

The FDA has granted investigational drug designation to Ananda Scientific Inc. for Nantheia ATL5, a liquid augmentative cannabidiol-based treatment for opioid use disorder, according to a company press release.

Simplifying the hepatitis C virus treatment process is essential to improving care among vulnerable populations, particularly people who inject drugs.

Researchers found a direct association between county-level opioid dispensing rate and individual-level prescription opioid misuse, misuse frequency and dependence, according to study results published in American Journal of Psychiatry.

Onsite screening with a fingerstick assay at addiction treatment centers increased diagnosis and treatment of hepatitis C among people who use drugs, researchers reported.

A multifaceted implementation initiative in nonaddiction clinics in the U.S. Veterans Affairs' health system appeared to increase prescribing of medications for opioid use disorder, according to study results published in JAMA Network Open.

The risk for a breakthrough SARS-CoV-2 infection was significantly higher among patients with a substance use disorder than those without one, a population-based cohort study showed.